Literature DB >> 12886016

Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.

Denise L Doolan1, Scott Southwood, Daniel A Freilich, John Sidney, Norma L Graber, Lori Shatney, Lolita Bebris, Laurence Florens, Carlota Dobano, Adam A Witney, Ettore Appella, Stephen L Hoffman, John R Yates, Daniel J Carucci, Alessandro Sette.   

Abstract

The recent explosion in genomic sequencing has made available a wealth of data that can now be analyzed to identify protein antigens, potential targets for vaccine development. Here we present, in the context of Plasmodium falciparum, a strategy that rapidly identifies target antigens from large and complex genomes. Sixteen antigenic proteins recognized by volunteers immunized with radiation-attenuated P. falciparum sporozoites, but not by mock immunized controls, were identified. Several of these were more antigenic than previously identified and well characterized P. falciparum-derived protein antigens. The data suggest that immune responses to Plasmodium are dispersed on a relatively large number of parasite antigens. These studies have implications for our understanding of immunodominance and breadth of responses to complex pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12886016      PMCID: PMC187898          DOI: 10.1073/pnas.1633254100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses.

Authors:  J W Yewdell; J R Bennink
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 2.  Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy.

Authors:  Y Kawakami; S A Rosenberg
Journal:  Int Rev Immunol       Date:  1997       Impact factor: 5.311

3.  Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals.

Authors:  Florian Kern; Torsten Bunde; Nicole Faulhaber; Felix Kiecker; Elham Khatamzas; Ina-Maria Rudawski; Axel Pruss; Jan-Willem Gratama; Rudolf Volkmer-Engert; Ralf Ewert; Petra Reinke; Hans-Dieter Volk; Louis J Picker
Journal:  J Infect Dis       Date:  2002-05-31       Impact factor: 5.226

4.  HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles.

Authors:  D L Doolan; S Southwood; R Chesnut; E Appella; E Gomez; A Richards; Y I Higashimoto; A Maewal; J Sidney; R A Gramzinski; C Mason; D Koech; S L Hoffman; A Sette
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

5.  Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis.

Authors:  A Sette; S Buus; E Appella; J A Smith; R Chesnut; C Miles; S M Colon; H M Grey
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Target antigens of purified human immunoglobulins which inhibit growth of Plasmodium falciparum in vitro.

Authors:  G V Brown; R F Anders; G F Mitchell; P F Heywood
Journal:  Nature       Date:  1982-06-17       Impact factor: 49.962

7.  The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors.

Authors:  I Kawashima; S J Hudson; V Tsai; S Southwood; K Takesako; E Appella; A Sette; E Celis
Journal:  Hum Immunol       Date:  1998-01       Impact factor: 2.850

8.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

9.  Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.

Authors:  K M Chang; N H Gruener; S Southwood; J Sidney; G R Pape; F V Chisari; A Sette
Journal:  J Immunol       Date:  1999-01-15       Impact factor: 5.422

10.  A proteomic view of the Plasmodium falciparum life cycle.

Authors:  Laurence Florens; Michael P Washburn; J Dale Raine; Robert M Anthony; Munira Grainger; J David Haynes; J Kathleen Moch; Nemone Muster; John B Sacci; David L Tabb; Adam A Witney; Dirk Wolters; Yimin Wu; Malcolm J Gardner; Anthony A Holder; Robert E Sinden; John R Yates; Daniel J Carucci
Journal:  Nature       Date:  2002-10-03       Impact factor: 49.962

View more
  113 in total

1.  CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance.

Authors:  Charles S Rosenberg; Dianya L Martin; Rick L Tarleton
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Large screen approaches to identify novel malaria vaccine candidates.

Authors:  D Huw Davies; Patrick Duffy; Jean-Luc Bodmer; Philip L Felgner; Denise L Doolan
Journal:  Vaccine       Date:  2015-10-01       Impact factor: 3.641

3.  Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications.

Authors:  Huynh-Hoa Bui; John Sidney; Bjoern Peters; Muthuraman Sathiamurthy; Asabe Sinichi; Kelly-Anne Purton; Bianca R Mothé; Francis V Chisari; David I Watkins; Alessandro Sette
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

Review 4.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

5.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

6.  Identification of a dominant CD4 T cell epitope in the membrane lipoprotein Tul4 from Francisella tularensis LVS.

Authors:  Michael D Valentino; Lucinda L Hensley; Denise Skrombolas; Pamela L McPherson; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Mol Immunol       Date:  2009-02-23       Impact factor: 4.407

7.  Characterization of the peptide-binding specificity of Mamu-A*11 results in the identification of SIV-derived epitopes and interspecies cross-reactivity.

Authors:  Alessandro Sette; John Sidney; Huynh-Hoa Bui; Marie-France del Guercio; Jeff Alexander; John Loffredo; David I Watkins; Bianca R Mothé
Journal:  Immunogenetics       Date:  2005-03-04       Impact factor: 2.846

8.  High-throughput generation of P. falciparum functional molecules by recombinational cloning.

Authors:  João Carlos Aguiar; Joshua LaBaer; Peter L Blair; Victoria Y Shamailova; Malvika Koundinya; Joshua A Russell; Fengying Huang; Wenhong Mar; Robert M Anthony; Adam Witney; Sonia R Caruana; Leonardo Brizuela; John B Sacci; Stephen L Hoffman; Daniel J Carucci
Journal:  Genome Res       Date:  2004-10       Impact factor: 9.043

Review 9.  Live attenuated pre-erythrocytic malaria vaccines.

Authors:  Gladys J Keitany; Marissa Vignali; Ruobing Wang
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

10.  Advances and challenges in malaria vaccine development.

Authors:  Ruobing Wang; Joseph D Smith; Stefan H I Kappe
Journal:  Expert Rev Mol Med       Date:  2009-12-16       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.